TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals (TCON) Financial Statements


TRACON Pharmaceuticals Financial Overview

TRACON Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.647; its P/E ratio is 1.20; TRACON Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 100.00K$ 3.04M-$ 9.00M-
Gross Profit$ 100.00K$ 3.04M-$ 9.00M-
EBIT$ -3.17M$ 464.00K$ 6.76M$ 2.46M$ -7.32M
EBITDA$ -3.16M$ 471.00K$ 7.44M$ 8.01M$ -6.18M
Net Income Common Stockholders$ -3.17M$ 439.00K$ 6.76M$ -6.29M$ -8.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.89M$ 8.56M$ 7.76M$ 1.74M$ 6.61M
Total Assets$ 9.36M$ 10.11M$ 9.41M$ 12.15M$ 8.36M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.89M$ -8.56M$ -7.76M$ -1.74M$ -6.61M
Total Liabilities$ 11.12M$ 10.91M$ 12.50M$ 27.93M$ 19.39M
Stockholders Equity$ -1.76M$ -809.00K$ -3.08M$ -15.74M$ -11.06M
Cash Flow-
Free Cash Flow$ -2.54M$ -522.00K$ 15.05M$ -5.85M$ -5.00M
Operating Cash Flow$ -2.54M$ -522.00K$ 15.05M$ -5.85M$ -5.00M
Investing Cash Flow-----
Financing Cash Flow$ 1.87M$ 1.32M$ -9.09M$ 1.05M$ -5.82M
Currency in USD

TRACON Pharmaceuticals Earnings and Revenue History

TRACON Pharmaceuticals Debt to Assets

TRACON Pharmaceuticals Cash Flow

TRACON Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis